Purchase Order 75N95021P00604

The National Institute on Drug Abuse awarded a purchase order to Quanterix Corporation for $46,936.00 on July 1, 2021, to administrate de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with final completion by September 30, 2023. Work is performed in Billerica, Massachusetts. The purchase order carries no set-aside designation and is priced on a firm fixed-price basis. The period of performance covers July 1, 2021 through June 30,...

<p>The National Institute on Drug Abuse issued a purchase order to Phenomenex, Inc. on September 8, 2021, valued at $10,591.45 for administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with ultimate completion on October 8, 2021. Place of performance is Baltimore, Maryland. The order is firm fixed price with no set-aside.</p>

The National Institute on Drug Abuse issued a purchase order to Life Technologies Corporation valued at $43,171.69 on December 14, 2018, for service contract renewal, with an ultimate completion date of December 13, 2021. This is a firm fixed price, no-set-aside simplified acquisition. Place of performance is Carlsbad, California. The order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September...

<p>The National Institute on Drug Abuse awarded a purchase order to Qiagen, LLC on September 16, 2021, with a firm fixed price ceiling value of $24,943.02 to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a). Place of performance is Baltimore, Maryland. The order's ultimate completion date was October 16, 2021.</p>

<p>The National Institute on Drug Abuse awarded a purchase order to Life Technologies Corporation for $16,990.88 on July 30, 2019. The order carries no set-aside designation and has a firm fixed price structure. Performance takes place in Carlsbad, California. The ultimate completion date is July 31, 2022. The order is part of the FY26 UDO Initiative.</p>

The National Institute on Drug Abuse issued a $136,499.26 delivery order to Eurofins Discovery Services North America, LLC on September 1, 2026, for receptor profile screening under a Total Small Business set-aside. Performance runs September 1, 2026 through August 31, 2027, at the awardee's facility in St. Charles, MO. The order is priced firm fixed price. Receptor profile screening supports the Institute's drug abuse research initiatives and involves advanced binding studies and related...

The National Institute on Drug Abuse issued a purchase order to Children's Hospital Medical Center valued at $28,175.00 on July 31, 2018, to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these fiscal year funds. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Ultimate completion...

The National Institute on Drug Abuse issued a purchase order to The Johns Hopkins University valued at $49,765.87 on September 21, 2021, to administrate de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these funds. Work is performed in Baltimore, Maryland. The order carries firm fixed-price pricing with an ultimate completion date of September 21, 2022....

The National Institute on Drug Abuse awarded a purchase order to Eckert &amp; Ziegler Radiopharma, Inc. for $76,350.00 on September 14, 2021. This firm fixed-price purchase order is for the administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these funds. The ultimate completion date is November 30, 2021. Work is performed in Wilmington,...

The National Institute on Drug Abuse issued a delivery order to Eurofins Discovery Services North America, LLC on September 26, 2023, with a ceiling value of $141,140.16 under a Total Small Business set-aside for receptor binding and predictive toxicology services. The order was issued under a $5 million single-award IDIQ with NIDA for receptor binding and predictive toxicology services through September 2028. Place of performance is Bethesda, MD. The period of performance runs from September...